<DOC>
	<DOCNO>NCT01000584</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness ( immune response ) license H1N12009 influenza vaccine adult give time prior seasonal influenza vaccine . The study enroll 300 adult ( age 20-59 year ) . Participants randomize 2 group . One group receive one dose license H1N1 vaccine one dose seasonal influenza vaccine time ; second group receive seasonal influenza vaccine 3 week receive license H1N12009 influenza vaccine . Study procedures include : medical history , blood sample complete memory aid . Participants involve study related procedure approximately 3-6 week depend upon group assignment .</brief_summary>
	<brief_title>Rapid Evaluation Pandemic H1N1 Influenza Vaccine Adults Receiving Seasonal Influenza Vaccine</brief_title>
	<detailed_description>The objective study two-fold : 1 . To evaluate safety immunogenicity H1N12009 influenza vaccine convenience sample adult , soon pandemic vaccine become available inform subsequent use vaccine public program . 2 . To evaluate compatibility co-administered H1N12009 pandemic vaccine seasonal TIV vaccine group subject , option co-administration would useful public program .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Written inform consent Adults 2059 year age Allergies egg , thimerosal , gentamicin sulphate , neomycin Lifethreatening reaction previous Flu vaccine Bleeding disorder Pregnancy Receipt blood blood product past 3 month Chronic illness Compromised immune system Previous labconfirmed H1N12009 infection Receipt H1N12009 vaccine Receipt Seasonal Influenza vaccine since March 2009</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>vaccine</keyword>
	<keyword>H1N1</keyword>
	<keyword>influenza</keyword>
	<keyword>H1N1 influenza vaccine</keyword>
	<keyword>influenza vaccine</keyword>
	<keyword>seasonal Influenza</keyword>
</DOC>